Wednesday 26 October

Drafting biotech patent applications

When and where

Date and time

Start: Wednesday 26 October 2022, 12:30 PM

End: Wednesday 26 October 2022, 01:30 PM

Event Overview

This lecture will provide a guide through key considerations relating to patent drafting in the biotech area.  It will discuss appropriate claim forms for common types of invention, the impact of specific issues of patentability on various biological technologies, and address commonly occurring problems in major jurisdictions.  It will also consider how key recent decisions impact upon patentability in this field, and look at approaches that can be used to address these when drafting.  It should be of particular interest to those starting out, or in the early stages of, a career in this area of the patent profession, while also providing information of relevance to more experienced practitioners.


All, Members, Non Members


Anna Gregson, Mathys & Squire

Anna Gregson, Mathys & Squire

Anna is a partner in Mathys & Squire’s biotech team, and is also based in their Manchester office.  She has worked with a broad range of clients, from university technology transfer organisations to international corporations.  Anna has experience in a wide range of subject matter in the fields of biotechnology and life sciences, including : vaccine technology; antibodies; viruses and virus-like particles; gene therapy; stem cells and related technologies; siRNA technology; biomarkers and diagnostics; rapid assay systems for the detection of infectious organisms; and recombinant protein technology, including neurotoxins. Anna also has significant expertise in the field of agri-tech, including transgenic plant technology and plant variety rights.

Iain Armstrong, Mathys & Squire

Iain Armstrong, Mathys & Squire

Iain has over 20 years experience in the patent profession, and during that time he has drafted hundreds of patent applications in the biotech area.  While he has a particular interest in cell biology and cell-based therapies, his drafting has covered a wide range of biologically-based technologies, including the medical uses of antibodies and other proteins, vaccine development, biomarker panels and diagnostic methods, molecular biology techniques, generation of biofuels and high value chemicals, and various research tools.  Iain is based in Mathys & Squire’s Manchester office.”

The event has been added to your basket:

Drafting biotech patent applications

Proceed to basket

Shopping Basket

No products in the cart.

Are you a CIPA member?

Sign in to your account to register for the event

Forgotten password?

If you are not yet registered or a member of CIPA, please register here

Skip to content